Artal Group S.A. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$172,100,000
-2.0%
1,000,000
-28.6%
3.85%
+8.0%
Q2 2021$175,686,000
-7.5%
1,400,0000.0%3.57%
+6.3%
Q1 2021$189,854,000
+6.0%
1,400,0000.0%3.36%
-12.7%
Q4 2020$179,116,000
+13.7%
1,400,0000.0%3.84%
+0.5%
Q3 2020$157,542,000
+18.1%
1,400,0000.0%3.82%
+2.5%
Q2 2020$133,378,000
-1.1%
1,400,000
-6.7%
3.73%
-34.5%
Q1 2020$134,805,000
+111.9%
1,500,000
+25.0%
5.70%
+131.8%
Q4 2019$63,624,000
+7.4%
1,200,000
-20.0%
2.46%
+3.5%
Q3 2019$59,265,000
-3.8%
1,500,0000.0%2.38%
-4.7%
Q2 2019$61,620,000
-28.5%
1,500,000
-18.9%
2.49%
-29.2%
Q1 2019$86,155,000
+58.3%
1,850,000
+48.0%
3.52%
+74.4%
Q4 2018$54,438,000
-4.9%
1,250,000
+25.0%
2.02%
+35.5%
Q3 2018$57,230,000
+7.2%
1,000,000
-9.1%
1.49%
+31.3%
Q2 2018$53,372,000
+60.6%
1,100,000
+29.4%
1.13%
+172.6%
Q1 2018$33,235,000
+4.4%
850,000
+13.3%
0.42%
-13.3%
Q4 2017$31,830,000
+21.8%
750,000
+7.1%
0.48%
+6.7%
Q3 2017$26,124,000
+22.8%
700,0000.0%0.45%
+21.0%
Q2 2017$21,273,000
+7.2%
700,000
-6.7%
0.37%
-15.6%
Q1 2017$19,853,000
+418.6%
750,000
+400.0%
0.44%
+418.8%
Q4 2016$3,828,000
-39.6%
150,000
-14.3%
0.08%
-32.0%
Q3 2016$6,333,000
+86.4%
175,000
+75.0%
0.12%
+78.6%
Q2 2016$3,398,000100,0000.07%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders